VRNA Shariah Compliance

Screening Methodology: AAOIFI

lock image
LOCKED

Analyst's Ratings for Verona Pharma PLC (VRNA)

Based on 17 analysts giving stock ratings to Verona Pharma PLC in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
29
Buy
65
Hold
6
Sell
0
Strong Sell
0
Verona Pharma PLC

Verona Pharma PLC. Stock Analysis VRNA

United States Health Care Mid Cap Report:
Verona Pharma Plc engages in the development and commercialization of therapeutics for the treatment of respiratory diseases. The firm is focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. Its product candidate, ensifentrine, is an investigational, inhaled, small molecule and dual inhibitor of the enzyme’s phosphodiesterase 3 and 4 (PDE3 and PDE4) combining bronchodilator and non-steroidal anti-inflammatory activities in one compound. The company is engaged in developing inhaled ensifentrine for the treatment of chronic obstructive pulmonary disease (COPD). The firm's two additional formulations of ensifentrine are in Phase II development for the treatment of COPD: dry powder inhaler (DPI) and pressurized metered-dose inhaler (pMDI). The firm's wholly owned subsidiary is Verona Pharma, Inc.
Read More

Verona Pharma PLC (VRNA) Chart

Key Statistics of Verona Pharma PLC (VRNA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$105.23$105.85

Today's Open

$105.78

Volume

906.87K

P/E Ratio (TTM)

-

52 Week Range

$11.39$81.73

Market Cap

6.29B

Avg. Volume

2.08M

Dividend Yield

-

Financial Metrics & Statements of Verona Pharma PLC (VRNA)

  • Per Share Data
  • Ratios
  • Statements
No data

No Data Available!

  • Annual Icon Annual
  • Quarterly Icon Quarterly
No data

No Annual Data Available!

FAQ's for Verona Pharma PLC (VRNA)

Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.